Suppr超能文献

人体结肠中的短链脂肪酸:与胃肠道健康和疾病的关系。

Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease.

作者信息

Mortensen P B, Clausen M R

机构信息

Dept. of Medicine CA, Rigshospitalet, University of Copenhagen, Denmark.

出版信息

Scand J Gastroenterol Suppl. 1996;216:132-48. doi: 10.3109/00365529609094568.

Abstract

Fermentation, the process whereby anaerobic bacteria break down carbohydrates to short-chain (C2-C6) fatty acids (SCFAs), is an important function of the large bowel. SCFAs constitute approximately two-thirds of the colonic anion concentration (70-130 mmol/l), mainly as acetate, propionate, and butyrate. Gastroenterologists have, in spite of these facts, addressed this scientific field surprisingly late, in contrast to veterinarians, for whom the fermentative production of SCFAs has been acknowledged as a principal mechanism of intestinal digestion in plant-eating animals for decades. Interest in the effects of SCFA production on the human organism has been growing rapidly in the last 10 years, because gastrointestinal functions and beneficial effects are associated with these acids. SCFAs are of major importance in the understanding of the physiological function of dietary fibre and their possible role for colonic neoplasia. SCFA production and absorption are closely related to the nourishment of the colonic mucosa and sodium and water absorption, and mechanisms of diarrhoea. Patients with severe malabsorption compensate by the fermentation of otherwise osmotic active saccharides to SCFAs, which are readily absorbed and used as energy fuels in the organism. SCFA production from dietary carbohydrates is a mechanism whereby considerable amounts of calories can be salvaged in short-bowel patients with remaining colonic function if dietary treatment is adjusted. SCFA enemas are a new and promising treatment modality for patients with ulcerative colitis. The effect has been attributed to the oxidation of SCFAs in the colonocytes. An impressive number of papers have described the effects of butyrate on various cell functions, the significance of which is still unknown. Up until now, attention has been related especially to cancer prophylaxis and treatment. Diminished production of SCFAs appears to be involved in antibiotic-associated diarrhoea, diversion colitis, and possibly in pouchitis. The interaction between bacterial fermentation, ammonia metabolism, and bacterial growth and protein synthesis appears to be the main mechanism of action of lactulose treatment in hepatic coma. Pathological and extremely high rates of saccharide fermentation explain the severe deterioration in patients with D-lactate acidosis. Hence, this scientific field has come late to clinical working gastroenterologists, but as work is progressing the production of SCFAs in the large bowel becomes involved in several well-known intestinal disorders.

摘要

发酵是厌氧菌将碳水化合物分解为短链(C2 - C6)脂肪酸(SCFAs)的过程,是大肠的一项重要功能。SCFAs约占结肠阴离子浓度的三分之二(70 - 130 mmol/l),主要为乙酸盐、丙酸盐和丁酸盐。尽管如此,与兽医相比,胃肠病学家涉足这一科学领域的时间却出奇地晚,几十年来,兽医们一直认为SCFAs的发酵产生是食草动物肠道消化的主要机制。在过去10年里,人们对SCFA产生对人体的影响的兴趣迅速增长,因为这些酸与胃肠功能和有益作用相关。SCFAs对于理解膳食纤维的生理功能及其在结肠肿瘤形成中可能的作用至关重要。SCFA的产生和吸收与结肠黏膜的营养、钠和水的吸收以及腹泻机制密切相关。严重吸收不良的患者通过将原本具有渗透活性的糖类发酵为SCFAs来进行代偿,SCFAs易于吸收并在体内用作能量燃料。如果调整饮食治疗,饮食碳水化合物产生SCFAs是一种可在仍保留结肠功能的短肠患者中挽救大量热量的机制。SCFA灌肠剂是治疗溃疡性结肠炎患者的一种新的、有前景的治疗方式。其效果归因于结肠细胞中SCFAs的氧化。大量论文描述了丁酸盐对各种细胞功能的影响,但其意义仍不明确。到目前为止,注意力尤其集中在癌症预防和治疗方面。SCFAs产生减少似乎与抗生素相关性腹泻、改道性结肠炎以及可能的袋炎有关。细菌发酵、氨代谢以及细菌生长和蛋白质合成之间的相互作用似乎是乳果糖治疗肝昏迷的主要作用机制。糖类发酵的病理性和极高速率解释了D - 乳酸酸中毒患者的严重病情恶化。因此,这个科学领域在临床胃肠病学家中起步较晚,但随着研究的进展,大肠中SCFAs的产生与几种知名的肠道疾病相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验